Market Insights Health Pharmacies OTC Products

Wound Care (Pharmacies) - Japan

Japan

Revenue in the Wound Care market is projected to reach US$156.40m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.33%, resulting in a market volume of US$158.50m by 2028.
In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
In relation to total population figures, per person revenues of US$1.27 are generated in 2024.

Key regions: South Korea, United States, Canada, United Kingdom, Australia

Market

Region

Region comparison

Currency

Analyst Opinion

The Wound Care (Pharmacies) market in Japan is experiencing significant growth due to changing customer preferences and emerging trends in the market.

Customer preferences: Customers in Japan are increasingly seeking convenience and accessibility when it comes to wound care products. They prefer to purchase these products from pharmacies, as they offer a wide range of options and are easily accessible to the general public. Additionally, customers in Japan value high-quality products that are effective in treating wounds and promoting healing. They are willing to pay a premium for products that are backed by scientific evidence and have a good reputation in the market.

Trends in the market: One of the key trends in the Wound Care (Pharmacies) market in Japan is the increasing demand for advanced wound care products. Customers are now looking for innovative solutions that can accelerate the healing process and reduce the risk of infection. This has led to the introduction of new products such as hydrogels, foam dressings, and silver-based dressings in the market. These products offer better moisture management, improved absorption capacity, and antimicrobial properties, making them highly desirable among customers. Another trend in the market is the growing focus on wound prevention. With an aging population and an increase in chronic diseases such as diabetes, there is a greater emphasis on preventing wounds from occurring in the first place. This has led to the development of preventive wound care products such as barrier creams, pressure-relieving devices, and diabetic foot care products. These products help in reducing the risk of wounds and promoting overall skin health.

Local special circumstances: Japan has a rapidly aging population, which has contributed to the growth of the Wound Care (Pharmacies) market. Older adults are more prone to wounds and require specialized wound care products. The government has also taken initiatives to improve wound care services for the elderly population, which has further fueled the demand for wound care products in the country.

Underlying macroeconomic factors: The Wound Care (Pharmacies) market in Japan is also influenced by macroeconomic factors such as healthcare expenditure and technological advancements. Japan has a well-established healthcare system and invests heavily in healthcare infrastructure. This has led to increased accessibility to wound care products and services, driving market growth. Additionally, advancements in technology have led to the development of innovative wound care products that are more effective and efficient in promoting healing. These technological advancements have further fueled the demand for wound care products in the country. In conclusion, the Wound Care (Pharmacies) market in Japan is witnessing significant growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for advanced wound care products and preventive solutions is driving market growth, while the aging population and government initiatives are also contributing to the expansion of the market. With continued focus on innovation and accessibility, the market is expected to grow further in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.